Stress Echocardiography in Mixed and Multi Valvular Heart Disease

Overview

  • Study type

    Observational
  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 16-006342
    Sponsor Protocol Number: 16-006342

About this study

This study aims to evaluate the diagnostic and prognostic value of SE in patients with mx/ml-VHD. As this is the first study of its kind, no preliminary data exists to perform power calculation.

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria:

Inclusion Criteria:

  • All adult patients with at least moderate mx/ml-VHD who had underwent a clinically indicated stress echocardiography study for their VHD prior to the date of IRB submission
  • Those who would be scheduled for a clinically indicated stress echo study at Mayo Clinic in the future (from the date of IRB submission, up to 31st Dec 2020).

Exclusion Criteria: 

  • Patients < 18 years old

 

 

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Patricia Pellikka, M.D.

Open for enrollment

Contact information:

Patricia Pellikka M.D.

(507)266-7432

pellikka.patricia@mayo.edu

.
CLS-20301842

Mayo Clinic Footer